NDC 0469-7220-01 - Cefizox
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0469-7220
- Requested NDC
- 0469-7220-01
- Package NDCs from labels
- 0469-7220-01
- Manufacturer
- Astellas Pharma US, Inc.
- Effective date
- 2006-01-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEFIZOX ® (ceftizoxime injection) IN GALAXY ® PLASTIC CONTAINER (PL2040) | Astellas Pharma US, Inc. | 2006-01-04 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0469-7220-01 | Cefizox | 50 mL in 1 BAG | SOLUTION | 50 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Ceftizoxime Sodium | ACTIVE INGREDIENT | 26337D5X88 | CEFIZOX (CEFTIZOXIME SODIUM) SOLUTION [ASTELLAS PHARMA US, INC.] | 1 | |
| Ceftizoxime | ACTIVE MOIETY | C43C467DPE | CEFIZOX (CEFTIZOXIME SODIUM) SOLUTION [ASTELLAS PHARMA US, INC.] | 1 | |
| Dextrose hydrous | INACTIVE INGREDIENT | LX22YL083G | CEFIZOX (CEFTIZOXIME SODIUM) SOLUTION [ASTELLAS PHARMA US, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| A822E39E-6974-0F15-C0B9-EBE4CAFB4F8B | 888998CC-C7F7-4F2A-8479-DF60F77BC2A1 | 2006-01-04 | Warnings, Adverse reactions | A822E39E-6974-0F15-C0B9-EBE4CAFB4F8B 888998CC-C7F7-4F2A-8479-DF60F77BC2A1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.